Global Intravenous Stopcock Market Share, Size 2021 Developing Rapidly with Recent Trends, Development, Revenue, Demand and Forecast to 2028

A recent report found on Qualiket Research Reports provides a comprehensive overview of the industry with a brief explanation. This overview discusses the definition of the product/service, primary applications of this product or service in different end-use industries. It also states the production and management technology employed for the same. The Global Intravenous Stopcock Market report has provided an in-depth analysis into some recent and noteworthy industry trends, the competitive landscape and analysis for specific regional segments for the forecast period of 2021 to 2028.

Get Sample Copy of this Report @

Intravenous stopcock is a type of ball valve medical device which regulated fluid delivery to vascular system. It is divided into various types including Three-way Stopcock, and Four-Way Stopcock. They are liquid and chemical resistance, transparent to enable bubble-detection easy to operate and smooth to turn.

Healthcare industry is expected to witness an exceptional growth over the next couple of years. The patient population is on the rise. Also, the outbreak of new diseases is expected to catalyze the expansion of the industry over the next couple of years. Investments are being constantly injected by the industry leaders for research & development. These researches, rising investment, drug discoveries, clinical trials, etc. are projected to accelerate revenue creation for the industry participants. These players are also anticipated to increase investments for the adoption of the latest technology, thus, propelling industry expansion.

Get Discount on this Report @

Increase in research and development activities of novel products and mergers and acquisitions adopted by key competitors are expected to boost the global intravenous stopcock market growth. Also, strategic collaborations among key competitors will positively contribute the market growth. For instance, in February 2017, Hospira Infusion system is acquired by ICU Medical Inc. This acquisition includes intravenous pumps, solutions and devices which Makes ICU medical one of the leading infusion therapy company which expected to propel the growth of intravenous stopcock market during this forecast period. Also, increase in attention towards patient safety will fuel the market growth. For instance, in April 2019, BD had launched new patient safety program in hospitals which is called as Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME).  It is developed in partnership with the Joint Commission International for patient’s safety.

Inquire Before Buying @

However, risk of contamination during use of intravenous stopcock is the major restraining factor which is expected to hinder the global intravenous stopcock market growth. Also, lack of skilled professionals in emerging economies like APAC, and MEA is projected to slow down the market growth during this analysis period.

Market Segmentation

Global Intravenous Stopcock Market is segmented into type such as Three-way Stopcock, and Four-Way Stopcock, by application such as Infusion Therapy, and Pressure Monitoring. Further, market is segmented into end user such as Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others.

Also, Global Intravenous Stopcock Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as

  • Fresenius Kabi AG,
  • Smith’s Medical,
  • SCW Medicath Ltd,
  • Global Medikit Limited,
  • Nordson Corporation,
  • BD,
  • Braun Medical Inc.,
  • Hospira Infusion system,
  • ICU medical Inc,
  • Terumo Medical Corporation, and
  • Baxter

Browse Full Research Report @

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A


Back to top button